T cell receptor delta joining 1 (TRDJ1)

T cell receptor delta joining 1 (TRDJ1) is a gene segment within the human TCRδ (T cell receptor delta) locus. It encodes a joining (J) region necessary for generating the variable domain of the TCR delta chain during V(D)J somatic recombination in developing T lymphocytes, particularly γδ T cells. The product of this gene segment is not a functional protein or receptor itself, but serves as a genomic component (joining segment) required for rearranging the TCRδ gene to create a mature, antigen-recognizing TCRδ chain. The TCR delta locus, including TRDJ1, is embedded within the TCR alpha locus and contributes to somatic recombination that yields diversity in the expressed TCR delta chain. This diversity is crucial for the immune system’s ability to recognize a broad spectrum of antigens. TRDJ1 is not a druggable protein, enzyme, receptor, or pharmacological target in itself; it is a gene segment critical for the genetic assembly of immune receptors, not a molecular target for drugs. Therefore, this genomic segment does not have direct therapeutic target potential; the assembled T cell receptor complex, not individual joining regions like TRDJ1, constitutes the antigen receptor and therapeutic target in immunomodulation or immunotherapy. Aliases such as "TCRD" typically refer to the entire T cell receptor delta locus, not this specific joining segment. There is something incorrect with treating TRDJ1 as a distinct molecular therapeutic target: it is a gene segment needed to assemble the T cell receptor delta chain but is not an individual protein, receptor, or druggable target itself.

Other names

TRDJ1TCRDT cell receptor delta joining 1